Factors associated with lower-risk cannabis use in adults in their mid-thirties [0.03%]
中年人较低风险使用大麻的相关因素
Guillaume Dubé,Jennifer O&#x;Loughlin,Jean-Sébastien Fallu et al.
Guillaume Dubé et al.
Background: Harm reduction strategies encourage people who use cannabis to adopt lower-risk behaviors, such as refraining from daily or intensive use or limiting simultaneous use with other psychoactive substances. Howeve...
From deficiency to toxicity: Magnesium increases cannabinoid and terpene production in cannabis plants [0.03%]
从缺乏到过量：镁增加大麻植物的 cannabinoid 和萜烯含量
Dalit Morad,Nirit Bernstein
Dalit Morad
Comparison of selected metals in the fillers of 14 commercial hemp cigarette brands to commercial tobacco cigarettes [0.03%]
14种市售 Hemp 雪茄与传统烟草雪茄中部分金属含量比较研究
Naudia R Gray,R Steven Pappas,Clifford H Watson
Naudia R Gray
Cannabis sativa L. containing < 0.3% delta-9 tetrahydrocannabinol (THC) is currently defined as hemp. Many different legal products in the United States now contain hemp and are marketed for their cannabinoid effects, as an alternative to t...
Prevalence and reasons for using cannabidiol, delta-8 tetrahydrocannabinol, cannabinol, cannabigerol, and hexahydrocannabinol among US adults [0.03%]
美国成年人中大麻二酚、Delta-8四氢大麻酚、大麻萜酚、大麻环素和六氢大麻素的使用率及原因分析
Nora Satybaldiyeva,Kevin H Yang,Wayne Kepner et al.
Nora Satybaldiyeva et al.
Background: Since the passage of the 2018 US Farm Bill there has been a market for cannabinoid products derived from Cannabis sativa L. that contain < 0.3% delta-9 tetrahydrocannabinol (THC). Understanding the characteris...
Application of thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) to estimate the normal boiling points of ∆9-tetrahydrocannabivarin (THCV) and ∆9-tetrahydrocannabinol (THC) [0.03%]
利用热重分析(TGA)和差示扫描量热法(DSC)估算 THCV 和 THC 的正常沸点
Eli H Turovsky,Kyle Moriarty,Nicole Chavarria et al.
Eli H Turovsky et al.
Economic feasibility and risk analysis of industrial hemp production: a comparative assessment of floral, fiber, and grain enterprises in North Carolina, USA [0.03%]
美国北卡罗来纳州三种大麻工业种植（花、纤维和粮食作物）的经济可行性和风险分析比较评估
Obed Quaicoe,Fafanyo Asiseh,Atta Aloka et al.
Obed Quaicoe et al.
Cannabidiol reduces LPS-induced inflammatory response in the human placenta by reducing NF-κB translocation [0.03%]
大麻二酚通过减少NF-κB转位来降低LPS诱导的胎盘炎症反应
Ramon Portillo,Tetiana Synova,Mohammad Rida Ghaddar et al.
Ramon Portillo et al.
Background: Cannabidiol (CBD), a non-psychoactive cannabinoid increasingly used during pregnancy, has been proposed to modulate inflammatory processes. However, its effects on human placental immune functions remain poorl...
Oil-based and oil-free formulations for enhancing cannabidiol bioavailability [0.03%]
基于油质和非油基的外用大麻二酚产品配方以增强其生物利用度
Petr Jelínek,Anežka Klouček,Ashley Hannah George et al.
Petr Jelínek et al.
Background: Cannabidiol (CBD) exhibits therapeutic potential due to its analgesic, anxiolytic, anti-inflammatory, and anticonvulsant effects. However, its oral bioavailability is limited by poor water solubility and exten...
Attitudes and expectations of primary care physicians regarding recreational cannabis legalization in Germany: a pre-implementation survey [0.03%]
德国关于娱乐性大麻合法化的基层医生态度和预期：实施前的调查研究
Uta Hochheim,Frank Müller,Eva Maria Noack
Uta Hochheim
Background: On April 1st, 2024, Germany legalized recreational cannabis use under specific conditions. While policymakers extensively debated this change, the perspectives of healthcare providers who will address its cons...
Medicinal use of non-prescribed cannabis: a cross-sectional survey on patterns of use, motives for use, and treatment access in the Netherlands [0.03%]
荷兰大麻非处方用药的医疗用途：使用模式、用药动机和治疗渠道的横断面调查研究
Lisa Strada,Simone Korteling,Mark Vergeer et al.
Lisa Strada et al.
Background: Despite the Netherlands having one of the world's oldest medical cannabis programs, the majority of people who use cannabis for medicinal purposes continue to rely on non-prescribed sources. This study investi...